Skip to main content

Bellevue Group AG

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1674546 Zurich, V8

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$112,806
+$24,445 QoQ
Shares Held
1,016
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#236
of 299 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. RYTM ranks #59 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RYTM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,806 1,016
2026-03-31 $88,361 1,016
2025-12-31 $803,228 7,504
2025-09-30 $914,262 9,053
2025-06-30 $1,321,050 20,906
2025-03-31 $823,683 15,550
2024-12-31 $1,320,904 23,596
2024-09-30 $822,523 15,700
2024-06-30 $533,780 13,000
2024-03-31 $541,625 12,500
2023-12-31 $1,510,987 32,869
2023-09-30 $1,680,402 73,300